Sorrento Therapeutics

Biotech layoffs gather pace as industry downturn persists
Biotech layoffs gather pace as industry downturn persists
BioPharma Dive
layoffs
biotech
Amgen
Pfizer
Roche
Jounce Therapeutics
Fate Therapeutics
Molecular Templates
Sorrento Therapeutics
Flag link:
Tangled in bankruptcy proceedings and legal tussle, Sorrento secures $75M to stay afloat
Tangled in bankruptcy proceedings and legal tussle, Sorrento secures $75M to stay afloat
Endpoints
Sorrento Therapeutics
bankruptcy
legal
Flag link:
Why Sorrento Therapeutics Stock Is Crashing Today
Why Sorrento Therapeutics Stock Is Crashing Today
Motley Fool
Sorrento Therapeutics
bankruptcy
Flag link:
Sorrento reports positive data from oral Covid-19 treatment trial
Sorrento reports positive data from oral Covid-19 treatment trial
Clinical Trials Arena
Sorrento Therapeutics
clinical trials
ovydso
COVID-19
China
Flag link:
Sorrento to begin Phase I trial of oral Covid-19 treatment
Sorrento to begin Phase I trial of oral Covid-19 treatment
Clinical Trials Arena
Sorrento Therapeutics
COVID-19
China
STI-1588
Flag link:
New Month, New Collaborations: BMS, Sorrento & Others Announce New Alliances
New Month, New Collaborations: BMS, Sorrento & Others Announce New Alliances
BioSpace
Bristol Myers Squibb
Immatics
Sorrento Therapeutics
prostate cancer
clinical trials
Caris Life Sciences
precision medicine
Flag link:
Which Company Has the Biggest COVID Program? The Answer Isn't Moderna.
Which Company Has the Biggest COVID Program? The Answer Isn't Moderna.
Motley Fool
COVID-19
Sorrento Therapeutics
Moderna Therapeutics
Pfizer
Flag link:
Edesa finds a signal in severely ill Covid-19 patients
Edesa finds a signal in severely ill Covid-19 patients
EP Vantage
Edesa Biotech
COVID-19
Sorrento Therapeutics
Synairgen
Implicit Bioscience
Atriva Therapeutics
Veru
Flag link:
Getting under your skin: Sorrento leveraging novel drug delivery platform to treat melanoma in tie-up with Mayo Clinic
Getting under your skin: Sorrento leveraging novel drug delivery platform to treat melanoma in tie-up with Mayo Clinic
BioPharma Dive
Sorrento Therapeutics
melanoma
R&D
Mayo Clinic
Flag link:
Why Sorrento Therapeutics Stock Is Skyrocketing Today
Why Sorrento Therapeutics Stock Is Skyrocketing Today
Motley Fool
Sorrento Therapeutics
clinical trials
COVI-MSC
COVID-19
Flag link:
Sorrento Therapeutics Cleared to Start Trial for Its Next-Generation Coronavirus Antibody Treatment
Sorrento Therapeutics Cleared to Start Trial for Its Next-Generation Coronavirus Antibody Treatment
Motley Fool
Sorrento Therapeutics
clinical trials
STI-1499
COVI-GUARD
COVID-19
Flag link:
Why Sorrento Therapeutics Stock Plunged Today
Why Sorrento Therapeutics Stock Plunged Today
Motley Fool
Sorrento Therapeutics
Flag link:
Sorrento picks up color-changing COVID-19 saliva test built by Columbia University fertility clinic
Sorrento picks up color-changing COVID-19 saliva test built by Columbia University fertility clinic
Fierce Biotech
diagnostics
Sorrento Therapeutics
COVID-19
Columbia University
Flag link:
Why Sorrento Therapeutics Shares Are Tumbling Today
Why Sorrento Therapeutics Shares Are Tumbling Today
Motley Fool
vaccines
Sorrento Therapeutics
Anthony Fauci
NIAID
COVID-19
Flag link:
Sorrento IDs Antibody Against COVID-19 That Appears 100% Effective
Sorrento IDs Antibody Against COVID-19 That Appears 100% Effective
BioSpace
antibodies
COVID-19
coronavirus
Sorrento Therapeutics
Flag link:
Sorrento and Mount Sinai Team Up for Antibody Cocktail COVI-SHIELD Project
Sorrento and Mount Sinai Team Up for Antibody Cocktail COVI-SHIELD Project
BioSpace
Sorrento Therapeutics
Mount Sinai
COVI-SHIELD
antibodies
antibody cocktail
COVID-19
Flag link:
Sorrento Therapeutics and Celularity Aim to Adapt Natural Killer Cell Therapy to Treat Coronavirus
Sorrento Therapeutics and Celularity Aim to Adapt Natural Killer Cell Therapy to Treat Coronavirus
Motley Fool
Sorrento Therapeutics
Celularity
natural killer cell therapy
cell therapy
coronaviruses
Wuhan Coronavirus
Flag link:
Sorrento shrugs off an anonymous private equity group’s $1B offer to buy the company
Sorrento shrugs off an anonymous private equity group’s $1B offer to buy the company
Endpoints
Sorrento Therapeutics
M&A
Flag link:
Why Sorrento Therapeutics Was Right to Reject Takeover Bids With A 245% Premium
Why Sorrento Therapeutics Was Right to Reject Takeover Bids With A 245% Premium
Motley Fool
Sorrento Therapeutics
M&A
ZTlido
Flag link:
The Week Ahead In Biotech: Pending Clinical Readouts In Focus
The Week Ahead In Biotech: Pending Clinical Readouts In Focus
Yahoo/Benzinga
Retrophin
Karyopharm
Celyad
uniQure
Sangamo Therapeutics
Catalyst Biosciences
Novo Nordisk
Reata Pharmaceuticals
Vertex Pharmaceuticals
Bellicum
Gilead Sciences
Jaguar Health
TRACON Pharmaceuticals
FibroGen
Aslan Pharma
ObsEva
Sorrento Therapeutics
Flag link:

Pages